Evelo Biosciences (NASDAQ:EVLO – Get Free Report) will likely be releasing its results on Tuesday, November 17th. Analysts expect Evelo Biosciences to announce earnings of ($10.1333) per share for the quarter.
Evelo Biosciences Trading Down 100.0%
The stock has a market capitalization of $2,000.00, a price-to-earnings ratio of -0.00 and a beta of 1.34. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00.
About Evelo Biosciences
Read More
- Five stocks we like better than Evelo Biosciences
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
